Rectal roflumilast improves trinitrobenzenesulfonic acid-induced chronic colitis in rats

Roflumilast, a highly selective oral phosphodiesterase IV inhibitor, exerts anti-inflammatory and anti-fibrotic effects. Oral roflumilast causes gastrointestinal side effects, especially vomiting, which could be reduced by administering roflumilast via off-label routes. Inhaled roflumilast reportedl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaikh-Omar, A., Murad, H.A., Alotaibi, N.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905672/
https://www.ncbi.nlm.nih.gov/pubmed/35239781
http://dx.doi.org/10.1590/1414-431X2021e11877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905672/
https://www.ncbi.nlm.nih.gov/pubmed/35239781
http://dx.doi.org/10.1590/1414-431X2021e11877

Ejemplares similares